ID

44999

Description

Principal Investigator: Richard Gilbertson, St. Jude Children's Research Hospital, Memphis, TN, USA MeSH: Medulloblastoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000409 Medulloblastoma is a heterogenous disease made up of at least four distinct subtypes of disease which appear to exploit and disrupt naturally occurring developmental pathways of cellular growth and hindbrain development. To better understand the driver mutations of this disease, we performed whole genome sequencing of 37 medulloblastomas and the corresponding normal DNA of the 37 affected children treated at St. Jude Children's Research Hospital. We have found several novel mutations which appear subtype specific. These mutations were checked for frequency in a separate tumor cohort of 56 children with medulloblastoma, also treated on the St. Jude Medulloblastoma 2003 trial, and were tested in several animal models of medulloblastoma for proof of oncogenic potential.

Link

https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000409

Keywords

  1. 7/1/22 7/1/22 - Dr. Christian Niklas
  2. 10/12/22 10/12/22 - Adrian Schulz
Copyright Holder

Richard Gilbertson, St. Jude Children's Research Hospital, Memphis, TN, USA

Uploaded on

July 1, 2022

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

dbGaP phs000409 Sequencing of Medulloblastoma

Eligibility Criteria

Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Cases of medulloblastoma treated at St. Jude Children's Hospital - St. Jude Medulloblastoma 2003 trial (SJMB03) with central pathology review confirming the diagnosis of medulloblastoma. The cases in this cohort have had whole genome sequencing of tumor and normal DNA performed. Cases were selected that had appropriate consent for genetic studies, and suitable material for sequencing (high purity tumor populations and available normal DNA).
Description

Elig.phs000409.v1.p1.1

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0025149
UMLS CUI [1,3]
C0332142
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C3640076
UMLS CUI [2,3]
C0027651
UMLS CUI [3,1]
C1512693
UMLS CUI [3,2]
C3640076
UMLS CUI [3,3]
C0332441
UMLS CUI [4,1]
C1512693
UMLS CUI [4,2]
C0021430
UMLS CUI [4,3]
C2827447
UMLS CUI [5,1]
C1512693
UMLS CUI [5,2]
C1547867
UMLS CUI [5,3]
C1328887

Similar models

Eligibility Criteria

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion and exclusion criteria
Elig.phs000409.v1.p1.1
Item
Cases of medulloblastoma treated at St. Jude Children's Hospital - St. Jude Medulloblastoma 2003 trial (SJMB03) with central pathology review confirming the diagnosis of medulloblastoma. The cases in this cohort have had whole genome sequencing of tumor and normal DNA performed. Cases were selected that had appropriate consent for genetic studies, and suitable material for sequencing (high purity tumor populations and available normal DNA).
boolean
C1512693 (UMLS CUI [1,1])
C0025149 (UMLS CUI [1,2])
C0332142 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C3640076 (UMLS CUI [2,2])
C0027651 (UMLS CUI [2,3])
C1512693 (UMLS CUI [3,1])
C3640076 (UMLS CUI [3,2])
C0332441 (UMLS CUI [3,3])
C1512693 (UMLS CUI [4,1])
C0021430 (UMLS CUI [4,2])
C2827447 (UMLS CUI [4,3])
C1512693 (UMLS CUI [5,1])
C1547867 (UMLS CUI [5,2])
C1328887 (UMLS CUI [5,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial